(Decrease) % December 31, 2018 December 31, 2017 Assets 954.82 787.13 167.69 21.30% Liabilities 283.75 123.43 160.32 129.89% Shareholders' equity 671.07 663.70 7.37 1.11% Issued and fully paid-up common share
0.12 (Twelve Satang) per share and total interim dividend payment of THB 36,000,000 (Thirty-six million baht). Allocated profit from the Board of Investment promoted activities (BOI) amount to THB 0.02
Company has been awarded ISO 13485, the Quality Management System for Medical Device Industry which is an important tool for competition and maintaining the product’s market share), the Company can maintain
97.71 207.89 Earnings per share (Baht per share) (0.01) 0.01 (0.02) (207.89) Net Profit The company and subsidiaries realized net profit (loss) of the 2nd quarter ended as of June 30, 2017, of THB (50.71
) 120.53 597.88 Earnings per share (Baht per share) 0.02 (0.00) 0.03 597.88 Net Profit The company and subsidiaries realized net prof it of the 3rd quarter ended as of September 30, 2017, of THB 100.37
) 120.53 597.88 Earnings per share (Baht per share) 0.022 (0.004) 0.026 597.88 Net Profit The company and subsidiaries realized net profit of the 3rd quarter ended as of September 30, 2017, of THB 100.37
. Within 9 months the competitors gradually disappeared and the company gained 50% market share. In the part of mobile top-up market share, the company gained it from several channels especially ROM. As a
Profit (Loss) (72.28) 42.70 (114.98) (269.26) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (269.26) Net Profit The company and subsidiaries realized net loss of Year 2017 ended as of December 31
) Net Profit (Loss) (72.28) 42.70 (114.98) (269.26) Earnings per share (Baht per share) (0.02) 0.01 (0.03) (269.26) Net Profit The company and subsidiaries realized net loss of Year 2017 ended as of
Wudhiprecha as an Independent Director and a member the Audit Committee, effective from 14 November 2018 onwards. December Increased share capital and allocated 597.0mn newly issued ordinary shares of the